Next Article in Journal
Millisecond Laser Oblique Hole Processing of Alumina Ceramics
Previous Article in Journal
Research on the Poisson’s Ratio of Black Phosphorene Nanotubes Under Axial Tension
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Cannabis Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance

by
Izabela Żółnowska
1,2,*,
Aleksandra Gostyńska-Stawna
1,*,
Anna Jelińska
1 and
Maciej Stawny
1
1
Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland
2
Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznan, Poland
*
Authors to whom correspondence should be addressed.
Nanomaterials 2025, 15(16), 1260; https://doi.org/10.3390/nano15161260
Submission received: 28 June 2025 / Revised: 2 August 2025 / Accepted: 13 August 2025 / Published: 15 August 2025
(This article belongs to the Section Nanofabrication and Nanomanufacturing)

Abstract

The therapeutic potential of cannabinoids and other ligands of cannabinoid receptors attracts considerable attention due to their diverse pharmacological effects and utility in various medical applications. However, challenges such as low solubility, limited bioavailability, and potential side effects hinder their broad clinical use. Nanoformulation techniques offer a promising approach to address these issues and optimize the therapeutic effectiveness of cannabinoids and other cannabinoid receptor ligands. This comprehensive review explores the advancements in nanoformulation strategies to enhance the therapeutic efficacy and safety of synthetic cannabinoids and related compounds, such as CB13, rimonabant, and HU-211, which have been studied in a range of preclinical models addressing conditions such as neuropathic pain, depression, and cancer. The review discusses various nanocarriers employed in this field, including lipid-based, polymeric, and hybrid nanoparticles, micelles, emulsions, and other nanoengineered carriers. In addition to formulation approaches, this review provides an in-depth analysis of chemical structures and their effect on compound activity, especially in the context of the affinity for the cannabinoid type 1 receptor in the brain, which is chiefly responsible for the psychoactive effects. The provided summary of research concerning either chemical modifications of existing cannabinoids or the creation of new compounds that interact with cannabinoid receptors, followed by the development of nanoformulations for these agents, allows for the identification of new research directions and future perspectives for Cannabis-based medicine. In conclusion, the combination of nanotechnology and cannabinoid pharmacology holds promise for delivering more effective and safer therapeutic solutions for a broad spectrum of medical conditions, making this an exciting area of research with profound implications for the healthcare and pharmaceutical industries.
Keywords: synthetic cannabinoids; nanotechnology; nanoformulations; cannabinoid structure synthetic cannabinoids; nanotechnology; nanoformulations; cannabinoid structure

Share and Cite

MDPI and ACS Style

Żółnowska, I.; Gostyńska-Stawna, A.; Jelińska, A.; Stawny, M. Cannabis Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance. Nanomaterials 2025, 15, 1260. https://doi.org/10.3390/nano15161260

AMA Style

Żółnowska I, Gostyńska-Stawna A, Jelińska A, Stawny M. Cannabis Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance. Nanomaterials. 2025; 15(16):1260. https://doi.org/10.3390/nano15161260

Chicago/Turabian Style

Żółnowska, Izabela, Aleksandra Gostyńska-Stawna, Anna Jelińska, and Maciej Stawny. 2025. "Cannabis Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance" Nanomaterials 15, no. 16: 1260. https://doi.org/10.3390/nano15161260

APA Style

Żółnowska, I., Gostyńska-Stawna, A., Jelińska, A., & Stawny, M. (2025). Cannabis Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance. Nanomaterials, 15(16), 1260. https://doi.org/10.3390/nano15161260

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop